CME Information
Provider Statement
This continuing medical education activity is provided by 
Support Statement
This activity is supported by educational grants from AbbVie Inc., Janssen Scientific Affairs, LLC, and Takeda Pharmaceuticals U.S.A., Inc.
Target Audience
The intended audience for this activity is gastroenterologists and other health care professionals involved in the management of patients with inflammatory bowel disease.
Learning Objectives
Upon successful completion of this activity, participants should be better able to summarize recent advances regarding the use of biologics and small molecules for the management of patients with IBD as well as the implications for clinical practice.
Activity Chair
David T. Rubin, MD
Joseph B. Kirsner Professor of Medicine
Section Chief, Gastroenterology, Hepatology and Nutrition
Inflammatory Bowel Disease Center
University of Chicago Medicine
Chicago, IL
Faculty
Bruce E. Sands, MD, MS
Chief, Dr. Henry D. Janowitz Division of Gastroenterology
Dr. Burrill B. Crohn Professor of Medicine
Icahn School of Medicine at Mount Sinai Hospital and Mount Sinai Health System
New York, NY
Reviewer
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, December 31, 2021, to December 30, 2022.
How to Participate in This Activity and Obtain CME Credit
To participate in this CME activity, you must read the learning objective, answer the polling and pretest questions, listen to the podcast, and complete the posttest and evaluation. Provide only one (1) correct answer for the question. A satisfactory score is defined as answering the posttest question correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Activity Chair and Faculty report the following relationship(s)
David T. Rubin, MD
Consultant: AbbVie, AltruBio, Allergan, Arena, Athos, Bellatrix, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene/Syneos, Connect Biopharma, Galen/Atlantica, Genentech/Roche, Gilead, InDex Pharmaceuticals, Ironwood Pharmaceuticals, Iterative Scopes, Janssen, Lilly, Materia Prima, Pfizer, Prometheus, Reistone, Takeda, Techlab
Independent Research Contractor: Takeda
Bruce E. Sands MD, MS
Consultant: AbbVie, Abivax, Amgen, Arena Pharmaceuticals, Artugen, AstraZeneca, Boehringer Ingelheim, Boston Pharmaceuticals, Bristol-Myers Squibb, Calibr, Celltrion, ClostraBio, Evommune, Galapagos, Genentech, Gilead, GlaxoSmithKline, Gossamer Bio, Index Pharmaceuticals, Inotrem, Ironwood Pharmaceuticals, Janssen, Kaleido Biosciences, Kallyope, Lilly, Pfizer, Prometheus, Protagonist Therapeutics, Q32 Bio, Sun, Surrozen, Takeda, Target RWE, Teva, Theravance, Ventryx, Viela Bio
Independent Research Contractor: Arena Pharmaceuticals, Theravance
Individual Stocks & Stock Option: Ventryx, Vivante
Reviewer reports the following relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
ADA Compliance
In compliance with the Americans with Disabilities Act of 1990, we will make all reasonable efforts to accommodate persons with disabilities. A text-based transcript of this Podcast is available upon request. Requests should include the Podcast title and can be emailed to cme@vindicoCME.com. Requests will be honored within 3-5 business days.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2021 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com